long-acting polysialic acid-protein conjugate (Xenetic Biosciences/Genentech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namelong-acting polysialic acid-protein conjugate (Xenetic Biosciences/Genentech)
Drug Alias Namelong-acting polysialic acid-protein conjugate (Lipoxen/Genentech)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenetic Biosciences (Uk) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A